Task: Answer the multiple choice question.
Query: Which compound exhibits a 4.711% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] O=C(CCC1CCCC1)Nc1nnc(-c2ccc3c(c2)OCO3)s1
[b] COc1ccc(-n2c(N)c(C(=O)NCC3CCCO3)c3nc4ccccc4nc32)c(OC)c1
Answer: a. O=C(CCC1CCCC1)Nc1nnc(-c2ccc3c(c2)OCO3)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCC1CCCC1)Nc1nnc(-c2ccc3c(c2)OCO3)s1
O=C(CCC1CCCC1)Nc1nnc(-c2ccc3c(c2)OCO3)s1
N-[5-(1,3-benzodioxol-5-yl)-1,3,4-thiadiazol-2-yl]-3-cyclopentylpropanamide